MIRA Pharmaceuticals, Inc.
General ticker "MIRA" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $21.2M (TTM average)
MIRA Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 44.3%.
Estimated limits based on current volatility of 3.9%: low 1.52$, high 1.65$
Factors to consider:
- Total employees count: 3 as of 2023
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.72$, 2.33$]
- 2025-12-31 to 2026-12-31 estimated range: [0.63$, 2.03$]
Short-term MIRA quotes
Long-term MIRA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $7.05MM | $8.53MM | $8.02MM |
| Operating Income | $-7.05MM | $-8.53MM | $-8.02MM |
| Non-Operating Income | $-0.01MM | $-3.46MM | $0.17MM |
| Interest Expense | $0.01MM | $3.46MM | $0.00MM |
| R&D Expense | $2.35MM | $1.57MM | $3.31MM |
| Income(Loss) | $-7.06MM | $-11.98MM | $-7.85MM |
| Profit(Loss)* | $-7.06MM | $-11.98MM | $-7.85MM |
| Stockholders Equity | $-0.60MM | $4.37MM | $2.20MM |
| Assets | $0.86MM | $4.93MM | $2.92MM |
| Operating Cash Flow | $-5.60MM | $-4.53MM | $-5.56MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $3.15MM | $8.78MM | $3.79MM |
| Earnings Per Share** | $-0.48 | $-0.65 | $-0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.